Gail Walkinshaw Selected Research

Cholesterol

1/2022	Contribution of HIF-P4H isoenzyme inhibition to metabolism indicates major beneficial effects being conveyed by HIF-P4H-2 antagonism.
1/2020	HIF-P4H-2 inhibition enhances intestinal fructose metabolism and induces thermogenesis protecting against NAFLD.
4/2016	Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gail Walkinshaw Research Topics

Disease

15	Hypoxia (Hypoxemia) 01/2020 - 05/2009
5	Inflammation (Inflammations) 01/2022 - 04/2016
4	Insulin Resistance 01/2022 - 10/2014
3	Ischemia 01/2014 - 07/2009
2	Anemia 01/2020 - 04/2016
2	Obesity 04/2016 - 10/2014
1	Hypertrophy 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Hyperglycemia 01/2022
1	Iron Deficiencies 01/2020
1	Chronic Renal Insufficiency 01/2020
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Alcoholic Fatty Liver 01/2019
1	Fatty Liver 01/2019
1	Atherosclerosis 04/2016
1	Atherosclerotic Plaque (Atheroma) 04/2016
1	Weight Gain 04/2016
1	Edema (Dropsy) 01/2014
1	Ischemic Stroke 01/2014
1	Brain Ischemia (Cerebral Ischemia) 01/2014
1	Brain Injuries (Brain Injury) 09/2013
1	Brain Diseases (Brain Disorder) 09/2013
1	Wounds and Injuries (Trauma) 09/2013
1	Stroke (Strokes) 09/2013
1	Epilepsy (Aura) 09/2013

Drug/Important Bio-Agent (IBA)

7	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 12/2019 - 10/2012
6	Transcription Factors (Transcription Factor)IBA 01/2020 - 07/2009
5	Oxygen (Dioxygen)IBA 01/2020 - 05/2009
5	FG-4497IBA 04/2016 - 07/2009
3	Messenger RNA (mRNA)IBA 01/2022 - 07/2012
3	CholesterolIBA 01/2022 - 04/2016
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2013
3	Glucose (Dextrose)FDA LinkGeneric 04/2016 - 01/2014
2	Prolyl-Hydroxylase InhibitorsIBA 01/2020 - 09/2013
2	Erythropoietin FDA Link 01/2020 - 01/2014
2	EnzymesIBA 12/2019 - 01/2017
2	cobaltous chloride (cobalt(II)chloride)IBA 04/2015 - 05/2009
2	Neuroprotective AgentsIBA 09/2013 - 07/2012
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2022
1	Leucine (L-Leucine)FDA Link 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2022
1	roxadustatIBA 01/2020
1	Choline (Choline Chloride)IBA 01/2020
1	FructoseIBA 01/2020
1	Hormones (Hormone)IBA 01/2020
1	IronIBA 01/2020
1	MetalsIBA 01/2020
1	Methionine (L-Methionine)FDA Link 01/2020
1	Peptidoglycan (Murein)IBA 01/2020
1	Polysaccharides (Glycans)IBA 01/2020
1	Cytochromes b (Cytochrome b)IBA 01/2020
1	HepcidinsIBA 01/2020
1	Ethanol (Ethyl Alcohol)IBA 01/2019
1	Lipoproteins (Lipoprotein)IBA 01/2019
1	AntioxidantsIBA 01/2019
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2017
1	oxidized low density lipoproteinIBA 04/2016
1	LDL Lipoproteins (beta Lipoproteins)IBA 04/2016
1	AutoantibodiesIBA 04/2016
1	LDL Receptors (LDL Receptor)IBA 04/2016
1	CopperIBA 04/2016
1	LipidsIBA 04/2016
1	Endothelins (Endothelin)IBA 04/2015
1	MimosineIBA 04/2015
1	Endothelin-Converting EnzymesIBA 04/2015
1	IsoenzymesIBA 10/2014
1	OccludinIBA 01/2014
1	Hypoxia-Inducible Factor-Proline DioxygenasesIBA 01/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014
1	Tight Junction ProteinsIBA 01/2014
1	activin AIBA 09/2013
1	Activins (Activin)IBA 09/2013
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2013
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 01/2013
1	Mixed Function Oxygenases (Monooxygenases)IBA 07/2012
1	Hemeproteins (Heme Protein)IBA 07/2012
1	NeuroglobinIBA 07/2012
1	dimethyloxallyl glycineIBA 05/2009
1	Deferoxamine (Desferal)FDA LinkGeneric 05/2009
1	Ciclopirox (Loprox)FDA LinkGeneric 05/2009

Therapy/Procedure

2	Therapeutics 01/2019 - 10/2014
1	Nephrectomy 01/2020